| Business

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Diamyd, with R&D here, inks $625M deal with J&J

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

'American Coyotes' Series

Traveling by Jeep, boat and foot, Tribune-Review investigative reporter Carl Prine and photojournalist Justin Merriman covered nearly 2,000 miles over two months along the border with Mexico to report on coyotes — the human traffickers who bring illegal immigrants into the United States. Most are Americans working for money and/or drugs. This series reports how their operations have a major impact on life for residents and the environment along the border — and beyond.

Staff and Wire Reports
Wednesday, June 23, 2010

Diamyd Medical AB, a Stockholm, Sweden-based company that maintains its research and development facilities in Pittsburgh, secured a major deal with a unit of Johnson & Johnson to develop and commercialize Diamyd's diabetes therapy.

The agreement over time could be worth more than $625 million to Ortho-McNeil-Janssen Pharmaceuticals Inc., the company said.

Diamyd came to Pittsburgh in 2005 when it acquired Nurel Therapeutics, founded by University of Pittsburgh scientists.

Darren Wolfe, CEO of Diamyd Inc. USA, said his R&D unit has more than doubled its work force in the last six months, to seven, and expects to employ 10 to 12 people within a year.

The company is housed within the Pittsburgh Life Sciences Greenhouse incubator at the Pittsburgh Technology Center in South Oakland. The Greenhouse also is an investor in Diamyd, having placed $100,000 in the local operations.

Subscribe today! Click here for our subscription offers.



Show commenting policy

Most-Read Stories

  1. Student ‘geek squad’ to help train Steel Valley classmates on iPads
  2. Road, entrance may ease traffic, Dayton Fair officials say
  3. Steelers’ Harrison awaits go-ahead from Tomlin before practicing
  4. One Direction brings the thrills to Heinz Field audience
  5. 4 ejections, benches-clearing scrum mark Pirates’ win over Reds
  6. Law enforcement often feels overwhelmed by Mon Valley’s heroin epidemic
  7. Slot cornerback Boykin should give Steelers options in secondary
  8. Steelers notebook: WR Bryant sidelined after minor procedure on right elbow
  9. Inaugural Geibel STEM camp gives pupils interactive, fun science experience
  10. Pa. breeding ground for corruption, experts say
  11. Pirates notebook: Burnett says ‘surgery is not an option’